Mission:
The Kuhn Lab is developing novel therapeutics and diagnostics approaches with a focus on cancer and viral infections.
Research efforts focus on
- the early detection and therapy management of cancer patients and
- the modulation of protein interactions for therapeutic intervention.
To learn more about the various projects of the Kuhn Lab, please visit the Projects and Labs page.
About Peter Kuhn
Peter's biography at Faculty of 1000
The research effort in the Kuhn Lab is principally supported by:
- private donations
- federal grants from the National Institutes of Health
- National Cancer Institute in support of the cancer diagnostic research (R01CA111359)
- National Institute for Allergy and Infectious Diseases in support of the SARS CoV research (HHSN266200400058C)
- National Institute of General Medical Sciences in support of the technology development in structural genomics (U54GM074961) and membrane protein research (5P50GM073197)
- National Center for Research Resources in support of the technology development program (U54GM074961)
- corporate contributions
- Novartis Institutes for Biomedical Research
- Microsoft Corporation